Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5875)
All Articles published online
|
Publishing Process of This Article
|
May 15, 2024 (publication date) through Dec 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Yang N, He LY, Liu P, Li ZY, Yang YC, Ping F, Xu LL, Li W, Zhang HB, Li YX. Dipeptidyl peptidase-4 inhibitors and the risk of infection: A systematic review and meta-analysis of cardiovascular outcome trials. World J Diabetes 2024; 15(5): 1011-1020 [PMID: 38766432 DOI: 10.4239/wjd.v15.i5.1011] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Yang N, He LY, Liu P, Li ZY, Yang YC, Ping F, Xu LL, Li W, Zhang HB, Li YX. Dipeptidyl peptidase-4 inhibitors and the risk of infection: A systematic review and meta-analysis of cardiovascular outcome trials. World J Diabetes 2024; 15(5): 1011-1020 [PMID: 38766432 DOI: 10.4239/wjd.v15.i5.1011] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i5/1011.htm |
| Number | Citing Articles |
| 1 |
Ehsan Amini-Salehi, Maryam Hasanpour, Abdulhadi Alotaibi, Pegah Rashidian, Seyyed Mohammad Hashemi, Amir Nasrollahizadeh, Negin Letafatkar, Parsa Saberian, Reza Amani-Beni, Najmeh Shanbehzadeh. Global research trends on DPP-4 inhibitors and cardiovascular outcomes: a comprehensive bibliometric analysis. Annals of Medicine & Surgery 2025; 87(4): 2133 doi: 10.1097/MS9.0000000000003089
|
| 2 |
Hsiao‐Wei Wang, Ming‐Hsien Tsai, Yu‐Wei Fang, Kuo‐Cheng Lu, Joshua Wang, Chien‐Lin Lu. Association between sodium‐glucose cotransporter 2 inhibitor use and clinical outcomes in patients with type 2 diabetes after urinary tract infection. Diabetes, Obesity and Metabolism 2025; 27(11): 6188 doi: 10.1111/dom.70003
|
| 3 |
Shumeng Han, Yiwen Liu, Baodi Xing, Yucheng Yang, Zijun Liu, Yixuan Li, Xuechen Wang, Jie Yu, Fan Ping, Wei Li, Lingling Xu, Tao Qi, Yuelun Zhang, Yuxiu Li, Huabing Zhang. Association of glucagon-like peptide-1 receptor agonist use with risk of infections: A systematic review and meta-analysis. Journal of Infection 2025; 91(5): 106645 doi: 10.1016/j.jinf.2025.106645
|
| 4 |
Laura Simon-Szabó, Beáta Lizák, Gábor Sturm, Anikó Somogyi, István Takács, Zsuzsanna Németh. Molecular Aspects in the Development of Type 2 Diabetes and Possible Preventive and Complementary Therapies. International Journal of Molecular Sciences 2024; 25(16): 9113 doi: 10.3390/ijms25169113
|